The Mini-Fellowship › Method and science › Clinical tools

The clinical tools.

Two instruments come out of this program and go into your practice: a structured screening tool for deciding who should be in the chair, and a clinical system that works out the dose, watches the infusion and follows the patient for a year afterwards. Both are taught, both are used during the four days, and both are honest about what they cannot do.

The Clinical Companion practice dashboard

The practice view in the Clinical Companion. The record shown is a teaching sample.

ToolsKIRT-S and the Clinical Companion
Taught inModules 8, 9, 11, 12 and 14
Included inTuition
Sold separatelyNot at present
KIRT-S validationNot prospectively validated
Plasma concentrationModeled, not measured

The KIRT-S

Who should be in the chair.

A one-page instrument that asks the same questions every time: eight hard-stop flags, four scored domains — substance use, psychiatric stability, medical and infusion safety, treatment fit — and a total out of eight that maps onto a named disposition.

It structures clinical judgment rather than replacing it, it has not been prospectively validated, and the page says so plainly.

The ketamine infusion risk assessment →

The KIRT-S running inside the Clinical Companion

The KIRT-S as it runs inside the Clinical Companion.

The KRI Clinical Companion

And what happens to them afterwards.

It scores the screen, weighs what the screen found, proposes a dose and the reasons for it, and then holds what actually happened — the labs, the infusion, the adverse events and the outcomes, in the order a patient moves through them. It models, it records, and it puts the right question in front of the person making the decision.

It is given to participants, used during the clinical sessions, and stays with graduates through the mentorship year.

The KRI Clinical Companion →

Outcome trends for one patient

Outcome trends plotted against the clinical threshold. The record shown is a teaching sample, not results from this program.

What both are, and are not

Neither is a device, and neither decides anything.

The KIRT-S is a screening aid, not a diagnostic instrument, and it has not been prospectively validated. The Companion models an expected plasma concentration; it does not measure one, because no bedside assay exists. Neither is FDA-cleared, neither is sold separately at present, and clinical decisions remain the responsibility of the treating clinician. Each page states its own limits in full.

What the evidence supports on individualizing a dose →
How the concentration is targeted →

Ketamine is FDA-approved as an anesthetic. Its use for depression, chronic pain and other psychiatric indications is off-label, which means the FDA has not evaluated it for those uses. Neither tool described on this page is an FDA-cleared medical device, and neither is a diagnostic instrument.

Both tools come home with you

Along with the Clinical Reference Manual, evaluation and consent templates, infusion records, controlled-substance logs and standard operating procedures.